Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Antonios Petropoulos who wrote (900)	3/16/1998 4:56:00 PM
From: Jack Ucci	Respond to of 1605

Steady above-average volume for 6 trading days with only sideways trading range. 1 million shares in 6 days: careful accumulation? By the definition of average this volume trend must end somewhere! Then what? A boost in the form of some company news would help before then. Jack

To: Antonios Petropoulos who wrote (900)	3/22/1998 11:50:00 AM
From: Mark Oliver	Respond to of 1605

Do you have any expectations from the coming conference? In conjunction with the American College of Cardiology (ACC), Medscape offers online coverage of ACC's 47th Annual Scientific Session from Atlanta from March 29 - April 1st. ACC '98 News Online puts a team of experienced cardiovascular physicians at your service producing in-depth, clinically-focused reviews of key sessions. Articles will appear online within 24 hours of the presentation's delivery in Atlanta. ACC '98 News Online offers you the opportunity to earn ACC Category I CME credit from your home or office. Point your browser to: medscape.com Medscape will take notes for you whether you are in Atlanta or elsewhere. It's the next best thing to being there. ACC '98 News Online is made possible through the generous support of Astra Merck.

To: Antonios Petropoulos who wrote (900)	3/22/1998 7:03:00 PM
From: Linda	Read Replies (1) \| Respond to of 1605

the hcva reinbursement piece is huge for those of you who may not be in tune with it. First of all vasomedical has huge potential because its non-invasive technique can be used in the non hospital clinic settings.. exactly what the restructuring of health care intends.. out of hospital treatments. In many parts of the USA HCVA is negotiating with states to convert medicaid to managed care.. i.e. more out-patient trends to capitate medical rates.. In addition, vaso's last financial report showed losses due to expansion in abroad... watch this report!..